| Jul 30 |
Cencora Q3 2024 Earnings Preview
|
| Jul 30 |
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
|
| Jul 26 |
Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 81% Above Its Share Price
|
| Jul 25 |
Do Options Traders Know Something About Cencora (COR) Stock We Don't?
|
| Jul 17 |
McKesson, Cardinal, Cencora interested in buying private cancer clinics - report
|
| Jul 12 |
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
|
| Jul 11 |
Why Cencora (COR) is Poised to Beat Earnings Estimates Again
|
| Jul 11 |
Investing in Cencora (NYSE:COR) five years ago would have delivered you a 179% gain
|
| Jul 9 |
A Closer Look at 4 Analyst Recommendations For Cencora
|
| Jul 8 |
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
|
